The Osteoporosis Drug market was valued at USD 15,576.30 Million in 2022 and is expected to reach USD 20,332.57 Million by 2030, growing at a CAGR of 4.68% (2023-2030). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.